Breaking the Mould — GlaxoSmithKline full-year results


Breaking the Mould — GlaxoSmithKline full-year results


Russ Mould, AJ Bell's Investment Director discusses GlaxoSmithKline, due to report full-year results on 3 February. He also looks at the first meeting of the Bank of England’s monetary policy committee.

Investments, Shares and the stockmarket | Fri, 29/01/2021 - 13:28 Share: